• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

December 15, 2019
Company Drug/Device Medical Condition Status
Nouscom NOUS-209 cancer Phase 1 trial initiated in subjects with microsatellite instable high gastric, colorectal and gastro-esophageal junction cancers in combination with the anti-PD-1 checkpoint inhibitor pembrolizumab at multiple centers in the U.S.
EicOsis LLC EC5026 pain management Phase 1a trial initiated enrolling healthy subjects
Oncternal Therapeutics TK216 Ewing Sarcoma Phase 1b expansion cohort initiated enrolling 18 subjects with relapsed or refractory Ewing Sarcoma at seven sites across the U.S.
Helix Biopharma L-DOS47 advanced pancreatic cancer Phase 1b/2 trial initiated in 20 subjects with advanced pancreatic cancer at the HonorHealth Scottsdale Osborn Medical Center in Scottsdale, Arizona
ProQR QR-1123 autosomal dominant retinitis pigmentosa Phase 1/2 trial initiated enrolling 35 subjects with autosomal dominant retinitis pigmentosa at sites in North America
Rocket Pharmaceuticals RP-L102 Fanconi Anemia Phase 2 trial initiated in 12 pediatric subjects with Fanconi Anemia at Lucile Packard Children’s Hospital Stanford and Hospital Infantil Universitario Niño Jesús
ImaginAb 89Zr-Df-IAB22M2C cancer and immune system imaging Phase 2 trial initiated enrolling subjects with advanced and metastatic cancer at Penn Medicine in Philadelphia, Pa.
Viela Bio VIB4920 Sjögren’s syndrome Phase 2b trial initiated enrolling subjects with Sjögren’s syndrome
Tonix Pharmaceuticals TNX-102 SL fibromyalgia Phase 3 trial initiated enrolling 470 subjects at 40 U.S. sites
Ocugen OCU300 ocular graft versus host disease Phase 3 trial initiated enrolling 60 subjects with ocular graft versus host disease
Eli Lilly LOXO-292 non-small cell lung cancer Phase 3 trial initiated enrolling 400 subjects
CStone Pharmaceuticals avapritinib advanced gastrointestinal stromal tumors Phase 3 trial initiated enrolling subjects with advanced gastrointestinal stromal tumors in China
Can-Fite Biopharma Piclidenoson moderate to severe plaque psoriasis Phase 3 trial initiated enrolling 407 subjects with moderate to severe plaque psoriasis in Europe, Israel and Canada
InMed Pharmaceuticals INM-755 epidermolysis bullosa Clinical Trial Authorization acceptance granted by the MHRA
CStone Pharmaceuticals CS3005 cancer Clinical Trial Authorization acceptance granted by the TGA
STAAR Surgical EVO/EVO+ VISIAN Toric Implantable Collamer Lens myopia with astigmatism IDE approval granted by the FDA
Abeona Therapeutics EB-101 recessive dystrophic epidermolysis bullosa IND approval granted by the FDA
CSL Behring Hizentra chronic inflammatory demyelinating polyneuropathy Orphan drug designation granted by FDA
VistaGen Therapeutics PH94B neuroactive nasal spray social anxiety disorder Fast Track Designation granted by the FDA
Dermira lebrikizumab moderate-to-severe atopic dermatitis Fast Track Designation granted by the FDA
Equillium itolizumab lupus nephritis Fast Track Designation granted by the FDA
Sarepta Therapeutics Vyondys 53 duchenne muscular dystrophy Accelerated approval granted by the FDA
OrthoGrid Systems PhantomMSK Trauma imaging for orthopedic surgery 510(k) Clearance granted by the FDA
TechMah Medical LimaCorporate Smart SPACE Shoulder 3D Planner & 3D Positioner 3D pre-operative planning and 3D positioners for intra-operative positioning 510(k) Clearance granted by the FDA
etectRx ID-Cap ingestible event marker Clearance granted by the FDA
AptarGroup Unidose Liquid System acute repetitive seizures Clearance granted by the FDA
Dyve Biosciences DYV-700 acute gout pain Approval granted by the FDA
Meitheal Pharmaceuticals Enoxaparin Sodium Injection, USP preventing blood clots Approval granted by the FDA
Amgen AVSOLA moderate-to-severe rheumatoid arthritis Approval granted by the FDA

 

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Virtual Doctoer

    Simple Changes Can Make Trials More Patient Friendly

  • Drug approval

    Two-Thirds of Trial Subjects for Drug Approvals Are Outside the U.S.

  • VaccinewithNeedle-360x240.png

    Rules of Vaccine Approval May Be Changing, But Statistical Analysis Tools Remain Constant

  • AskTheExperts-360x240.png

    Ask the Experts: Trial Operations Adjustments in a Remote World

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing